Vaccine against human T cell leukemia-lymphoma virus type I: progress and prospects.
Bomford
R
R
Unité d'Epidémiologie des Virus Oncogènes, Institut Pasteur, Paris, France.
Kazanji
M
M
De Thé
G
G
D000818:Animals; D005240:Feasibility Studies; D015368:Human T-lymphotropic virus 1 / Q000276:immunology*; D015367:Human T-lymphotropic virus 2 / Q000276:immunology*; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000517:prevention & control*; D015493:Paraparesis, Tropical Spastic / Q000517:prevention & control*; D014765:Viral Vaccines / Q000276:immunology*
D014765:Viral Vaccines